FDA Drug Application (010040) for RENOVIST by BRACCO

Back to FDA Applications sponsored by BRACCO

Application Number010040
Product Number020
FormINJECTABLE;INJECTION
Dosage34.3%;35%
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRENOVIST
Active IngredientDIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Active IngredientCount
List of drugs with Active Ingredient DIATRIZOATE MEGLUMINE31
List of drugs with Active Ingredient DIATRIZOATE SODIUM21


Back to FDA Applications sponsored by BRACCO